Website News and Research

RSS

First Edition: October 19, 2010

Today's major health policy headlines include reports about the latest developments in Virginia's court challenge against the health law, a U.S. government lawsuit targeting Michigan Blue Cross Blue Shield for anti-trust activities and a study about the Department of Health and Human Services' Hospital Compare.

19 Oct 2010

Tri-City Medical Center receives national Telly award

Tri-City Medical Center's Public Affairs and Marketing Department has spent the last 18 months working successfully on all fronts to improve the image and increase public awareness of the hospital. For those efforts, the department has earned itself a slew of prestigious national awards in print, web and video media.

19 Oct 2010

Medworxx highlights new opportunities in Patient Flow solution

Medworxx Solutions Inc announced today that it has issued an update to its strategy roadmap, highlighting new opportunities in the Patient Flow area internationally.

19 Oct 2010

Shift in agriculture techniques required to ensure future food security, U.N. special rapporteur on right to food says on World Food Day

Farming techniques must adapt to mitigate the effects of climate change and ensure global food security, Olivier De Schutter, the U.N. special rapporteur on the right to food, said in a statement to mark Saturday's World Food Day, Agence France-Presse reports.

19 Oct 2010

New website provides access to hospice care

Hospice Care of South Carolina, the largest hospice care provider in South Carolina, recently launched a new website designed to help people facing an advanced illness and their loved ones gain earlier access to hospice care.

19 Oct 2010

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on odanacatib, an investigational cathepsin-K (Cat-K) inhibitor in development for the treatment of osteoporosis in postmenopausal women, were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, Canada.

19 Oct 2010

Althea installs INOVA H3-5 high-speed syringe filling line

Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.

19 Oct 2010

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Having an egg allergy is not a reason to avoid getting the 2010-2011 flu vaccination.

19 Oct 2010

Somaxon announces nonreceipt of Paragraph IV certification for generic Silenor ANDA

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that the website of the U.S. Food and Drug Administration (FDA) indicates that an Abbreviated New Drug Application (ANDA) for a generic version of Silenor® (doxepin) 3 mg and 6 mg was submitted on September 16, 2010.

19 Oct 2010

New report reinforces the evidence for exceptional returns from health research

A Lateral Economic’s Report “The Economic Value of Australia’s Investment in Health and Medical Research,” provides an up to date analysis of the pay-back of the significant investment by the Australian Government and business community in HMR in Australia.

18 Oct 2010

Visiting biotech leader urges policymakers to support Australian innovation

The future of the Australian biotechnology industry relies on support from policymakers to ensure an economic environment and public policy regime that encourages innovation, says Jim Greenwood, president and CEO of Biotechnology Industry Organization (BIO). Speaking ahead of AusBiotech 2010, Mr Greenwood believes that strong government support is needed to ensure the continued success of Australian biotech.

18 Oct 2010

PetMed second quarter Net sales decreases 1.9% to $61.2 million

PetMed Express, Inc. today announced its financial results for the quarter ended September 30, 2010.

18 Oct 2010

Nektar presents data of NKTR-181 mu-opioid analgesic candidate at Pain 2010 Symposium

Nektar Therapeutics presented promising data today from preclinical studies of NKTR-181, a next-generation mu-opioid analgesic candidate with a novel molecular design. NKTR-181 is being developed to effectively treat pain while addressing the abuse liability and serious side effects associated with traditional opioid therapies.

18 Oct 2010

Catholic officials approve Caritas sale in Mass., Boston and Milwaukee hospitals strengthen their financial standing

Catholic church officials have signed off on the sale of Caritas Christi Health Care to a private equity firm, according to a document filed with the Supreme Judicial Court.

18 Oct 2010

Neogenix to present NPC-1C antibody data at ASCO Annual Meeting

Neogenix Oncology, Inc. announced today that it will present data from its new serum biomarker ELISA utilizing its NPC-1C antibody for patients with colorectal and pancreatic cancers. Results from the study will be presented at the American Society of Clinical Oncology (ASCO)-NCI-EORTC Annual Meeting on Molecular Makers in Cancer, to be held in Hollywood, Florida from October 18-20, 2010.

18 Oct 2010

Tips to help keep teeth and gums healthy

Good nutrition and healthy eating habits are essential to maintaining optimal oral and overall health. With Halloween just around the corner, the Pennsylvania Dental Association (PDA) encourages parents to be mindful of the amount of candy their children are consuming, and to use this holiday as an opportunity to remind them about the importance of taking care of their teeth and gums.

15 Oct 2010

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.

15 Oct 2010

UBM Medica acquires OBGYN.net from MediSpecialty.com

UBM Medica today announces that it has acquired the website OBGYN.net from MediSpecialty.com, Inc.

15 Oct 2010

FDA approves Cephalon's REMS for GABITRIL

Cephalon, Inc. today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA). The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.

15 Oct 2010

Anti-vaccination group loses charitable status

An anti-vaccination group that has been in the news for all the wrong reasons recently has been stripped of its charitable status after the state government found its fund raising appeals had not been conducted in good faith. The Australian Vaccination Network (AVN) came into news when in July it was ordered to publish a disclaimer on its website stating the group was anti-vaccination and its material should not be read as medical advice.

14 Oct 2010